Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy crawled time : 13:30 save search
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
Published: 2024-03-18 (Crawled : 13:30) - biospace.com/
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 0.46%
H: 0.23%
C: -1.88%
acquisition
Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period
Published: 2024-02-12 (Crawled : 13:30) - biospace.com/
RYZB | $62.49 0.03% 280K
|
|
| O: 0.12%
H: 0.0%
C: 0.0%
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 0.02%
H: 0.46%
C: -0.14%
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: -0.14%
H: 0.35%
C: -1.12%
lung opdivo cancer cell
NeuroTrauma Sciences Appoints William Fricker, CPA, MBA, as Chief Financial Officer
Published: 2024-01-09 (Crawled : 13:30) - prnewswire.com
JNJ | News | $149.575 0.31% 2.5M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 0.5%
H: 0.1%
C: -1.48%
sciences financial
Bristol Myers Squibb to Present at J.P. Morgan’s 42nd Annual Healthcare Conference
Published: 2023-12-22 (Crawled : 13:30) - biospace.com/
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
conference
Abilita Bio Appoints Dan Bradbury to its Newly Formed Board of Directors
Published: 2022-02-23 (Crawled : 13:30) - prnewswire.com
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 0.67%
H: 0.57%
C: 0.04%
ICPT | $19.0 -0.05% 4M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: -6.22%
EQ | $1.77 7.27% 35K
|
Health Technology
|
| O: 1.36%
H: 1.6%
C: -1.07%
CSTL | $20.355 3.8% 59K
|
Health Technology
|
| O: 1.78%
H: 0.98%
C: -2.53%
Idiopathic Pulmonary Fibrosis Market to Reach $6.16 Bn, Globally, by 2030 at 7.0% CAGR: Allied Market Research
Published: 2022-02-07 (Crawled : 13:30) - prnewswire.com
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 2.69%
H: 0.5%
C: -1.76%
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: 3.7%
H: 1.64%
C: 1.24%
GLPG | News | $29.575 1.74% 49K
|
Health Technology
|
| O: 2.54%
H: 1.58%
C: 0.1%
FGEN | $1.15 0.88% 700K
|
Health Technology
|
| O: -1.09%
H: 9.3%
C: 8.82%
BIIB | $194.93 0.42% 210K
|
Health Technology
|
| O: 2.54%
H: 0.0%
C: 0.0%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: -0.14%
H: 1.01%
C: 0.87%
fibrosis research
Anokion Announces Progress Across Pipeline of Novel Autoimmune Programs
Published: 2022-01-06 (Crawled : 13:30) - biospace.com/
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: -1.17%
H: 0.11%
C: -0.39%
program
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.595 164.08% 13M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
MTC | $2.28 46.15% 2.6M
|
Technology Services
OPRT | News | $3.14 39.56% 7.6M
|
Finance
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.865 33.21% 2.4M
|
n/a
PALI | $6.37 29.21% 21M
|
Manufacturing
LOCL | $3.33 27.59% 43K
|
Your saved searches
Save your searches and get alerts when important news are released.